Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Bafilomycin C1: Precision V-ATPase Inhibitor in Autophagy As
2026-05-30
Bafilomycin C1 stands out as a gold-standard vacuolar H+-ATPases inhibitor for dissecting lysosomal function and autophagy in high-content screening workflows. This article bridges deep-learning-driven phenotypic screening with practical assay design, troubleshooting, and protocol fine-tuning—empowering researchers to achieve reproducible, quantifiable insights in fields from cancer biology to iPSC-based cardiotoxicity profiling.
-
Trelagliptin Promotes Osteoblastic Differentiation via RUNX2
2026-05-29
The reference study uncovers that Trelagliptin, a DPP-4 inhibitor originally developed for type 2 diabetes, significantly enhances osteoblastic differentiation by upregulating RUNX2 through an AMPK-dependent pathway. These findings highlight a novel therapeutic avenue for osteoporosis and clarify a key mechanistic link between metabolic regulation and bone formation.
-
Ridaforolimus: mTOR Inhibition Workflows for Cancer Research
2026-05-29
Ridaforolimus (Deforolimus, MK-8669) empowers researchers with precision mTOR pathway inhibition, enabling robust antiproliferative and anti-angiogenic studies across diverse cancer models. This guide distills best practices, workflow optimizations, and troubleshooting tips to accelerate translational research using APExBIO’s high-purity Ridaforolimus.
-
HyperScript RT SuperMix for qPCR: Mechanisms and Benchmarks
2026-05-28
HyperScript RT SuperMix for qPCR optimizes cDNA synthesis for gene expression analysis, using a genetically engineered reverse transcriptase with enhanced stability. This review details the mechanistic features enabling reliable reverse transcription of complex RNA templates and presents evidence-based claims for its use in sensitive qPCR assays.
-
iRhom2 Modulates Olfactory Receptor Regulation and Adaptatio
2026-05-28
The featured study elucidates the role of iRhom2 in olfactory sensory neurons, demonstrating its selective expression and regulatory function in odorant receptor adaptation. These findings provide a new molecular link between sensory stimulation, receptor gene expression, and adaptive feedback in the olfactory system.
-
Cell Counting Kit-8 Plus: Elevating Senolytic Assay Rigor
2026-05-27
Explore how Cell Counting Kit-8 Plus advances tetrazolium salt assays for senolytic research, including nuanced assay selection insights from recent ATP1A1-targeted studies. Discover protocol best practices and decision points not covered in previous articles.
-
PXR Activation Regulates Water Homeostasis via Hypothalamic
2026-05-27
This study reveals that hypothalamic PXR activation, using pregnenolone-16α-carbonitrile, directly enhances urine concentration by upregulating arginine vasopressin gene expression. These findings identify a previously unrecognized neuroendocrine role for PXR, with implications for understanding and potentially targeting water balance disorders.
-
2-D08 (2’,3’,4’-trihydroxyflavone): Selective Sumoylation In
2026-05-26
2-D08 (2’,3’,4’-trihydroxyflavone) enables precise inhibition of protein sumoylation, uniquely blocking UBC9-mediated SUMO transfer without affecting upstream E1 or ubiquitin pathways. Its robust application in cancer and mitophagy models empowers researchers to dissect posttranslational modification networks with exceptional specificity.
-
Ordered DNA Frameworks Boost Enzymatic Oligonucleotide Synth
2026-05-26
A recent study introduces tetrahedral DNA nanostructures (TDN) as a highly ordered interface that dramatically enhances enzymatic oligonucleotide synthesis (EOS). By improving enzyme accessibility and reducing synthesis errors, this approach enables higher-fidelity, longer DNA synthesis with major implications for DNA storage and molecular biology.
-
Precision Fluorescent RNA Probe Engineering with HyperScribe
2026-05-25
Explore advanced Cy5 RNA labeling with the HyperScribe T7 High Yield Cy5 RNA Labeling Kit. This article uniquely bridges mechanistic probe design, application-specific optimization, and translational assay decision-making.
-
Griseofulvin: Microtubule Associated Inhibitor for Fungal As
2026-05-25
Griseofulvin stands out as a high-purity, DMSO-soluble microtubule associated inhibitor, enabling robust dissection of fungal cell mitosis and aneugenicity in vitro. This guide delivers step-by-step protocols, troubleshooting insights, and experimental benchmarks that help researchers harness APExBIO’s Griseofulvin for advanced antifungal and cell cycle studies.
-
Butylhydroxyanisole (BHA): Reliable Antioxidant for ROS Assa
2026-05-24
This article provides a scenario-driven, evidence-based exploration of Butylhydroxyanisole (BHA, SKU C6525) as a synthetic antioxidant for oxidative stress and cell viability research. Drawing on real laboratory challenges, it demonstrates how BHA enables reproducible reactive oxygen species (ROS) detection and apoptosis pathway studies, with protocol guidance and vendor selection insights for biomedical researchers.
-
Fingolimod (FTY720): Bridging S1P Modulation & In Vivo Immun
2026-05-23
This thought-leadership article unpacks the mechanistic underpinnings and strategic opportunities of Fingolimod (FTY720) as both an immunomodulator and a neuroprotective agent—focusing on translational workflows that bridge classic multiple sclerosis indications with emerging in vivo immune cell engineering. The discussion integrates recent advances in magnetic nano-antibody-enabled CAR-T-mimicking cells and positions APExBIO’s high-purity Fingolimod as a research-grade standard for innovative immunology and neuroprotection.
-
Oligo (dT) 25 Beads: Optimizing Eukaryotic mRNA Isolation Wo
2026-05-22
Oligo (dT) 25 Beads enable rapid, high-purity eukaryotic mRNA isolation with minimal hands-on time—streamlining multiomics and transcriptome research. This article translates cutting-edge findings and real-world troubleshooting into actionable guidance for superior molecular workflows.
-
Salinomycin in Hepatocellular Carcinoma: Mechanistic Insight
2026-05-22
Explore Salinomycin, a polyether ionophore antibiotic, as a precise tool for dissecting anti-cancer mechanisms in hepatocellular carcinoma research. This article uniquely bridges advanced in vitro assay interpretation with mechanistic depth, offering scientists new clarity for experimental design.